Advertisement

Sex, Gender, and Transgender: Metabolic Impact of Cross Hormone Therapy

  • Roberta de Souza Santos
  • Aaron P. Frank
  • Michael Douglas Nelson
  • Maurice M. Garcia
  • Biff F. Palmer
  • Deborah J. Clegg
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1043)

Abstract

Most preclinical and clinical, animal, and human research has been biased with respect to sex and even more so with respect to gender. In fact, little is known about the impact of sex and even less about the influence of gender on overall metabolic processes. The National Institutes of Health has recognized this gap in scientific knowledge and now mandates that studies be conducted in both sexes and to include gender as variables influencing physiological processes such as metabolism. It is therefore critical to understand and appreciate how to incorporate sex and gender in preclinical and clinical research in order to enhance our understanding of the mechanisms by which metabolic processes differ by sex and gender. In this chapter, we define sex and gender and discuss when sex and gender are not aligned, such as that which occurs in transgender individuals, and how this impacts metabolic processes. We discuss the importance of understanding the influence and interactions between sex hormones and sex chromosomes rather than focusing on their relative contributions to metabolism in isolation. This knowledge will optimize therapies specific for individuals which need to encompass sex and gender.

References

  1. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders. Arlington, VA: American Psychiatric Publishing.CrossRefGoogle Scholar
  2. Andreazza, T. S., Costa, A. B., Massuda, R., Salvador, J., Silveira, E. M., Piccon, F., Carvalho, R., Fontanari, A. M., Koff, W., Belmonte-De-Abreu, P., & Lobato, M. I. (2014). Discordant transsexualism in male monozygotic twins: Neuroanatomical and psychological differences. Archives of Sexual Behavior, 43, 399–405.CrossRefPubMedGoogle Scholar
  3. Bekhouche, Y. H. R., Tyson, L. D., & Zahidi, S. (2015). The global gender gap report, 2015. Geneva, Switzerland: World Economic Forum.Google Scholar
  4. Bellott, D. W., Hughes, J. F., Skaletsky, H., Brown, L. G., Pyntikova, T., Cho, T. J., Koutseva, N., Zaghlul, S., Graves, T., Rock, S., Kremitzki, C., Fulton, R. S., Dugan, S., Ding, Y., Morton, D., Khan, Z., Lewis, L., Buhay, C., Wang, Q., Watt, J., Holder, M., Lee, S., Nazareth, L., Alfoldi, J., Rozen, S., Muzny, D. M., Warren, W. C., Gibbs, R. A., Wilson, R. K., & Page, D. C. (2014). Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature, 508, 494–499.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006). Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 91, 1995–2010.CrossRefPubMedGoogle Scholar
  6. Bojesen, A., Juul, S., Birkebaek, N., & Gravholt, C. H. (2004). Increased mortality in Klinefelter syndrome. The Journal of Clinical Endocrinology and Metabolism, 89, 3830–3834.CrossRefPubMedGoogle Scholar
  7. Burke, S. M., Cohen-Kettenis, P. T., Veltman, D. J., Klink, D. T., & Bakker, J. (2014a). Hypothalamic response to the chemo-signal androstadienone in gender dysphoric children and adolescents. Frontier Endocrinology (Lausanne), 5, 60.Google Scholar
  8. Burke, S. M., Menks, W. M., Cohen-Kettenis, P. T., Klink, D. T., & Bakker, J. (2014b). Click-evoked otoacoustic emissions in children and adolescents with gender identity disorder. Archives of Sexual Behavior, 43, 1515–1523.CrossRefPubMedGoogle Scholar
  9. Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K. S., & Simpson, E. R. (1997). Effect of testosterone and estradiol in a man with aromatase deficiency. The New England Journal of Medicine, 337, 91–95.CrossRefPubMedGoogle Scholar
  10. Charchar, F. J., Bloomer, L. D., Barnes, T. A., Cowley, M. J., Nelson, C. P., Wang, Y., Denniff, M., Debiec, R., Christofidou, P., Nankervis, S., Dominiczak, A. F., Bani-Mustafa, A., Balmforth, A. J., Hall, A. S., Erdmann, J., Cambien, F., Deloukas, P., Hengstenberg, C., Packard, C., Schunkert, H., Ouwehand, W. H., Ford, I., Goodall, A. H., Jobling, M. A., Samani, N. J., & Tomaszewski, M. (2012). Inheritance of coronary artery disease in men: An analysis of the role of the Y chromosome. Lancet, 379, 915–922.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Chen, X., Watkins, R., Delot, E., Reliene, R., Schiestl, R. H., Burgoyne, P. S., & Arnold, A. P. (2008). Sex difference in neural tube defects in p53-null mice is caused by differences in the complement of X not Y genes. Developmental Neurobiology, 68, 265–273.CrossRefPubMedGoogle Scholar
  12. Clayton, J. A., & Collins, F. S. (2014). Policy: NIH to balance sex in cell and animal studies. Nature, 509, 282–283.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Collins, P., Stevenson, J. C., & Mosca, L. (2002). Spotlight on gender. Cardiovascular Research, 53, 535–537.CrossRefPubMedGoogle Scholar
  14. Coolidge, F. L., Thede, L. L., & Young, S. E. (2002). The heritability of gender identity disorder in a child and adolescent twin sample. Behavior Genetics, 32, 251–257.CrossRefPubMedGoogle Scholar
  15. Cooper, G. S., & Sandler, D. P. (1998). Age at natural menopause and mortality. Annals of Epidemiology, 8, 229–235.CrossRefPubMedGoogle Scholar
  16. Dai, R., & Ahmed, S. A. (2014). Sexual dimorphism of miRNA expression: A new perspective in understanding the sex bias of autoimmune diseases. Therapeutics and Clinical Risk Management, 10, 151–163.PubMedPubMedCentralGoogle Scholar
  17. Dai, W., Li, Y., & Zheng, H. (2012). Estradiol/testosterone imbalance: Impact on coronary heart disease risk factors in postmenopausal women. Cardiology, 121, 249–254.CrossRefPubMedGoogle Scholar
  18. Deng, X., Berletch, J. B., Nguyen, D. K., & Disteche, C. M. (2014). X chromosome regulation: Diverse patterns in development, tissues and disease. Nature Reviews. Genetics, 15, 367–378.CrossRefPubMedPubMedCentralGoogle Scholar
  19. Dokras, A. (2013). Cardiovascular disease risk in women with PCOS. Steroids, 78, 773–776.CrossRefPubMedGoogle Scholar
  20. Fagegaltier, D., Konig, A., Gordon, A., Lai, E. C., Gingeras, T. R., Hannon, G. J., & Shcherbata, H. R. (2014). A genome-wide survey of sexually dimorphic expression of Drosophila miRNAs identifies the steroid hormone-induced miRNA let-7 as a regulator of sexual identity. Genetics, 198, 647–668.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Finkelstein, J. S., Lee, H., Burnett-Bowie, S. A., Pallais, J. C., Yu, E. W., Borges, L. F., Jones, B. F., Barry, C. V., Wulczyn, K. E., Thomas, B. J., & Leder, B. Z. (2013). Gonadal steroids and body composition, strength, and sexual function in men. The New England Journal of Medicine, 369, 1011–1022.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Firtser, S., Juonala, M., Magnussen, C. G., Jula, A., Loo, B. M., Marniemi, J., Viikari, J. S., Toppari, J., Perheentupa, A., Hutri-Kahonen, N., & Raitakari, O. T. (2012). Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24–45 years. The Cardiovascular Risk in Young Finns Study. Atherosclerosis, 222, 257–262.CrossRefPubMedGoogle Scholar
  23. Flores, A., Herman, J., Gates, G., & Brown, T. (2016). How many adults identify as transgender in the United States. Los Angeles, CA: The Williams Institute.Google Scholar
  24. Gates, G. J. (2011). How many people are lesbian, gay, bisexual, and transgender? Los Angeles, CA: The Williams Institute.Google Scholar
  25. Gong, Y., Xiao, H., Li, C., Bai, J., Cheng, X., Jin, M., Sun, B., Lu, Y., Shao, Y., & Tian, H. (2013). Elevated t/e2 ratio is associated with an increased risk of cerebrovascular disease in elderly men. PLoS One, 8, e61598.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Gooren, L. J., Kreukels, B., Lapauw, B., & Giltay, E. J. (2015). (Patho)physiology of cross-sex hormone administration to transsexual people: The potential impact of male-female genetic differences. Andrologia, 47, 5–19.CrossRefPubMedGoogle Scholar
  27. Guillamon, A., Junque, C., & Gomez-Gil, E. (2016). A review of the status of brain structure research in transsexualism. Archives of Sexual Behavior, 45, 1615–1648.CrossRefPubMedPubMedCentralGoogle Scholar
  28. Hassold, T., & Hunt, P. (2001). To err (meiotically) is human: The genesis of human aneuploidy. Nature Reviews. Genetics, 2, 280–291.CrossRefPubMedGoogle Scholar
  29. Hausmann, R., Tyson, L. D., & Zahidi, S. (2012). The global gender gap report, 2012. Geneva, Switzerland: World Economic Forum.Google Scholar
  30. Hembree, W. C., Cohen-Kettenis, P., Delemarre-Van De Waal, H. A., Gooren, L. J., Meyer, W. J., 3rd, Spack, N. P., Tangpricha, V., & Montori, V. M. (2009). Endocrine treatment of transsexual persons: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 94, 3132–3154.CrossRefPubMedGoogle Scholar
  31. Heylens, G., De Cuypere, G., Zucker, K. J., Schelfaut, C., Elaut, E., Vanden Bossche, H., De Baere, E., & T’Sjoen, G. (2012). Gender identity disorder in twins: A review of the case report literature. The Journal of Sexual Medicine, 9, 751–757.CrossRefPubMedGoogle Scholar
  32. Izadnegahdar, M., Singer, J., Lee, M. K., Gao, M., Thompson, C. R., Kopec, J., & Humphries, K. H. (2014). Do younger women fare worse? Sex differences in acute myocardial infarction hospitalization and early mortality rates over ten years. Journal of Women’s Health (2002), 23, 10–17.CrossRefGoogle Scholar
  33. Jacobsen, B. K., Nilssen, S., Heuch, I., & Kvale, G. (1997). Does age at natural menopause affect mortality from ischemic heart disease? Journal of Clinical Epidemiology, 50, 475–479.CrossRefPubMedGoogle Scholar
  34. Jankowska, E. A., Rozentryt, P., Ponikowska, B., Hartmann, O., Kustrzycka-Kratochwil, D., Reczuch, K., Nowak, J., Borodulin-Nadzieja, L., Polonski, L., Banasiak, W., Poole-Wilson, P. A., Anker, S. D., & Ponikowski, P. (2009). Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA, 301, 1892–1901.CrossRefPubMedGoogle Scholar
  35. Kannel, W. B., & Wilson, P. W. (1995). Risk factors that attenuate the female coronary disease advantage. Archives of Internal Medicine, 155, 57–61.CrossRefPubMedGoogle Scholar
  36. Kauth, M. R., Shipherd, J. C., Lindsay, J., Blosnich, J. R., Brown, G. R., & Jones, K. T. (2014). Access to care for transgender veterans in the Veterans Health Administration: 2006–2013. American Journal of Public Health, 104(Suppl 4), S532–S534.CrossRefPubMedPubMedCentralGoogle Scholar
  37. Kawase, K., Kwong, A., Yorozuya, K., Tomizawa, Y., Numann, P. J., & Sanfey, H. (2013). The attitude and perceptions of work-life balance: A comparison among women surgeons in Japan, USA, and Hong Kong China. World Journal of Surgery, 37, 2–11.CrossRefPubMedGoogle Scholar
  38. Klinefelter, H., Reifenstein, E., & Albright, F. (1942). Syndrome characterized by gynecomastia, aspermatogenesis without A-leydigism, and increased excretion of follicle-stimulating hormone. The Journal of Clinical Endocrinology & Metabolism, 2, 615–627.CrossRefGoogle Scholar
  39. Korasz, K., & Simon, L. (2008). Overview of the biological etiology of transsexualism. Orvosi Hetilap, 149, 1555–1560.CrossRefPubMedGoogle Scholar
  40. Lentini, E., Kasahara, M., Arver, S., & Savic, I. (2013). Sex differences in the human brain and the impact of sex chromosomes and sex hormones. Cerebral Cortex, 23, 2322–2336.CrossRefPubMedGoogle Scholar
  41. Marshall Graves, J. A. (2002). The rise and fall of SRY. Trends in Genetics, 18, 259–264.CrossRefPubMedGoogle Scholar
  42. Martin-Subero, J. I. (2011). How epigenomics brings phenotype into being. Pediatric Endocrinology Reviews, 9(Suppl 1), 506–510.PubMedGoogle Scholar
  43. Mauvais-Jarvis, F. (2014). Developmental androgenization programs metabolic dysfunction in adult mice: Clinical implications. Adipocytes, 3, 151–154.CrossRefGoogle Scholar
  44. Mauvais-Jarvis, F., Arnold, A. P., & Reue, K. (2017). A guide for the design of pre-clinical studies on sex differences in metabolism. Cell Metabolism, 25, 1216–1230.CrossRefPubMedGoogle Scholar
  45. Mazure, C. M., & Jones, D. P. (2015). Twenty years and still counting: Including women as participants and studying sex and gender in biomedical research. BMC Women’s Health, 15, 94.CrossRefPubMedPubMedCentralGoogle Scholar
  46. Monks, D. A., Johansen, J. A., Mo, K., Rao, P., Eagleson, B., Yu, Z., Lieberman, A. P., Breedlove, S. M., & Jordan, C. L. (2007). Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proceedings of the National Academy of Sciences of the United States of America, 104, 18259–18264.CrossRefPubMedPubMedCentralGoogle Scholar
  47. Morgan, C. P., & Bale, T. L. (2012). Sex differences in microRNA regulation of gene expression: No smoke, just miRs. Biology of Sex Differences, 3, 22.CrossRefPubMedPubMedCentralGoogle Scholar
  48. Navarro, G., Allard, C., Xu, W., & Mauvais-Jarvis, F. (2015). The role of androgens in metabolism, obesity, and diabetes in males and females. Obesity (Silver Spring), 23, 713–719.CrossRefGoogle Scholar
  49. Nelson, M. D., Szczepaniak, L. S., Wei, J., Szczepaniak, E., Sánchez, F. J., Vilain, E., Stern, J. H., Bergman, R. N., Bairey Merz, C. N., & Clegg, D. J. (2016). Transwomen and the metabolic syndrome: Is orchiectomy protective? Transgender Health, 1, 165–171.CrossRefPubMedPubMedCentralGoogle Scholar
  50. Nieuwenhoven, L., & Klinge, I. (2010). Scientific excellence in applying sex- and gender-sensitive methods in biomedical and health research. Journal of Women’s Health (2002), 19, 313–321.CrossRefGoogle Scholar
  51. NIH Revitalization Act of 1993. (1993). 42 U.S.C. Google Scholar
  52. Passarge, E. (1995). Colour atlas of genetics. New York, NY: Thieme Medical Publishers.Google Scholar
  53. Phillips, S. P. (2005). Defining and measuring gender: A social determinant of health whose time has come. International Journal for Equity in Health, 4, 11.CrossRefPubMedPubMedCentralGoogle Scholar
  54. Phoenix, C. H., Goy, R. W., Gerall, A. A., & Young, W. C. (1959). Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. Endocrinology, 65, 369–382.CrossRefPubMedGoogle Scholar
  55. Ren, J., & Kelley, R. O. (2009). Cardiac health in women with metabolic syndrome: Clinical aspects and pathophysiology. Obesity, 17, 1114–1123.PubMedGoogle Scholar
  56. Royo, H., Seitz, H., Elinati, E., Peters, A. H., Stadler, M. B., & Turner, J. M. (2015). Silencing of X-linked microRNAs by meiotic sex chromosome inactivation. PLoS Genetics, 11, e1005461.CrossRefPubMedPubMedCentralGoogle Scholar
  57. Sadeghi, M., & Fakhrai, A. (2000). Transsexualism in female monozygotic twins: A case report. The Australian and New Zealand Journal of Psychiatry, 34, 862–864.CrossRefPubMedGoogle Scholar
  58. Schwarcz, M. D., & Frishman, W. H. (2010). Testosterone and coronary artery disease. Cardiology in Review, 18, 251–257.CrossRefPubMedGoogle Scholar
  59. Sharma, S., & Eghbali, M. (2014). Influence of sex differences on microRNA gene regulation in disease. Biology of Sex Differences, 5, 3.CrossRefPubMedPubMedCentralGoogle Scholar
  60. Simon, L., Kozak, L. R., Simon, V., Czobor, P., Unoka, Z., Szabo, A., & Csukly, G. (2013). Regional grey matter structure differences between transsexuals and healthy controls – A voxel based morphometry study. PLoS One, 8, e83947.CrossRefPubMedPubMedCentralGoogle Scholar
  61. Skafar, D. F., Xu, R., Morales, J., Ram, J., & Sowers, J. R. (1997). Female sex hormones and cardiovascular disease in women. The Journal of Clinical Endocrinology & Metabolism, 82, 3913–3918.Google Scholar
  62. Smith, E. S., Junger, J., Derntl, B., & Habel, U. (2015). The transsexual brain – A review of findings on the neural basis of transsexualism. Neuroscience and Biobehavioral Reviews, 59, 251–266.CrossRefPubMedGoogle Scholar
  63. Snyder, P. J., Bhasin, S., Cunningham, G. R., Matsumoto, A. M., Stephens-Shields, A. J., Cauley, J. A., Gill, T. M., Barrett-Connor, E., Swerdloff, R. S., Wang, C., Ensrud, K. E., Lewis, C. E., Farrar, J. T., Cella, D., Rosen, R. C., Pahor, M., Crandall, J. P., Molitch, M. E., Cifelli, D., Dougar, D., Fluharty, L., Resnick, S. M., Storer, T. W., Anton, S., Basaria, S., Diem, S. J., Hou, X., Mohler, E. R., 3rd, Parsons, J. K., Wenger, N. K., Zeldow, B., Landis, J. R., & Ellenberg, S. S. (2016). Effects of testosterone treatment in older men. The New England Journal of Medicine, 374, 611–624.CrossRefPubMedPubMedCentralGoogle Scholar
  64. Sosa, E., Flores, L., Yan, W., & Mccarrey, J. R. (2015). Escape of X-linked miRNA genes from meiotic sex chromosome inactivation. Development, 142, 3791–3800.CrossRefPubMedPubMedCentralGoogle Scholar
  65. Sozzi, F. B., Danzi, G. B., Foco, L., Ferlini, M., Tubaro, M., Galli, M., Celli, P., & Mannucci, P. M. (2007). Myocardial infarction in the young: A sex-based comparison. Coronary Artery Disease, 18, 429–431.CrossRefPubMedGoogle Scholar
  66. Steensma, T. D., Kreukels, B. P., De Vries, A. L., & Cohen-Kettenis, P. T. (2013). Gender identity development in adolescence. Hormones and Behavior, 64, 288–297.CrossRefPubMedGoogle Scholar
  67. Swerdlow, A. J., Hermon, C., Jacobs, P. A., Alberman, E., Beral, V., Daker, M., Fordyce, A., & Youings, S. (2001). Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: A cohort study. Annals of Human Genetics, 65, 177–188.CrossRefPubMedGoogle Scholar
  68. The Mayo Clinic. (2016a). Triple X syndrome [online]. Available: http://www.mayoclinic.org/diseases-conditions/triple-x-syndrome/home/ovc-20164620?p=1. Accessed 9 May 2016.
  69. The Mayo Clinic. (2016b). Turner syndrome [online]. Available: http://www.mayoclinic.org/diseases-conditions/turner-syndrome/basics/definition/con-20032572. Accessed 20 June 2016.
  70. Tivesten, A., Vandenput, L., Labrie, F., Karlsson, M. K., Ljunggren, O., Mellstrom, D., & Ohlsson, C. (2009). Low serum testosterone and estradiol predict mortality in elderly men. The Journal of Clinical Endocrinology and Metabolism, 94, 2482–2488.CrossRefPubMedGoogle Scholar
  71. U.S. National Library of Medicine. (2016). Your guide to understanding genetic conditions [online]. Available: https://ghr.nlm.nih.gov/condition/triple-x-syndrome. Accessed 9 May 2016.
  72. Wierckx, K., Elaut, E., Declercq, E., Heylens, G., De Cuypere, G., Taes, Y., Kaufman, J. M., & T’Sjoen, G. (2013). Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: A case-control study. European Journal of Endocrinology, 169, 471–478.CrossRefPubMedGoogle Scholar
  73. Wijchers, P. J., Yandim, C., Panousopoulou, E., Ahmad, M., Harker, N., Saveliev, A., Burgoyne, P. S., & Festenstein, R. (2010). Sexual dimorphism in mammalian autosomal gene regulation is determined not only by Sry but by sex chromosome complement as well. Developmental Cell, 19, 477–484.CrossRefPubMedGoogle Scholar
  74. Wintermantel, T. M., Campbell, R. E., Porteous, R., Bock, D., Grone, H. J., Todman, M. G., Korach, K. S., Greiner, E., Perez, C. A., Schutz, G., & Herbison, A. E. (2006). Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility. Neuron, 52, 271–280.CrossRefPubMedGoogle Scholar
  75. Wise, A. L., Gyi, L., & Manolio, T. A. (2013). eXclusion: Toward integrating the X chromosome in genome-wide association analyses. American Journal of Human Genetics, 92, 643–647.CrossRefPubMedPubMedCentralGoogle Scholar
  76. Wu, H., Luo, J., Yu, H., Rattner, A., Mo, A., Wang, Y., Smallwood, P. M., Erlanger, B., Wheelan, S. J., & Nathans, J. (2014). Cellular resolution maps of X chromosome inactivation: Implications for neural development, function, and disease. Neuron, 81, 103–119.CrossRefPubMedPubMedCentralGoogle Scholar
  77. Yanes, L. L., & Reckelhoff, J. F. (2011). Postmenopausal hypertension. American Journal of Hypertension, 24, 740–749.CrossRefPubMedGoogle Scholar
  78. Zubiaurre-Elorza, L., Junque, C., Gomez-Gil, E., & Guillamon, A. (2014). Effects of cross-sex hormone treatment on cortical thickness in transsexual individuals. The Journal of Sexual Medicine, 11, 1248–1261.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Roberta de Souza Santos
    • 1
  • Aaron P. Frank
    • 1
  • Michael Douglas Nelson
    • 2
    • 3
    • 4
    • 5
  • Maurice M. Garcia
    • 6
    • 7
    • 8
  • Biff F. Palmer
    • 9
  • Deborah J. Clegg
    • 1
  1. 1.Biomedical Research Department, Diabetes and Obesity Research DivisionCedars-Sinai Medical CenterLos AngelesUSA
  2. 2.Applied Physiology and Advanced Imaging LabUniversity of TexasArlingtonUSA
  3. 3.KinesiologyUniversity of TexasArlingtonUSA
  4. 4.BioengineeringUniversity of TexasArlingtonUSA
  5. 5.Cedars-Sinai Medical CenterUniversity of TexasArlingtonUSA
  6. 6.Division of UrologyCedars-Sinai Medical CenterLos AngelesUSA
  7. 7.Cedars-Sinai Medical Center Transgender Surgery and Health ProgramLos AngelesUSA
  8. 8.Department of UrologyUniversity of California San FranciscoSan FranciscoUSA
  9. 9.Department of Internal MedicineUniversity of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations